|
Triazolidinedione vs. second generation Sulfonylureas |
|||
| Missing |
P |
Int |
Inc |
| (XP) |
(XI) |
(XInc) |
|
|
|
|||
| XTJ, XMC |
11.35 ± 1.32 |
[10.91, 11.88] ± [1.20, 1.38] |
10.9 ± 1.53 |
Ma et al. BMC Medical Research Methodology 2008 8:56 doi:10.1186/1471-2288-8-56 |
|||